Demystifying the science behind targeted treatments and immunotherapies for malignant melanoma (virtual course)
Over the course of one morning Dr Elaine Vickers provides an up-to-date overview of the science behind targeted treatments and immunotherapies for people with malignant melanoma.
Event: Study days and conferences
Elaine begins with the gene mutations that cause melanoma and describes the biology of this disease and its relationship with the immune system. She then describes various treatment approaches, such as B-Raf and MEK inhibitors and immunotherapy with checkpoint inhibitors.
8th July 2021Description_melanoma-virtual-morning_Elaine-Vickers_July2022.pdf
Size: 217.98KB Published Date: January 2020 Last updated: March 2021
9th July 2021Science Communicated events calendar 2021-2023_1.pdf
Size: 167.21KB Published Date: September 2020 Last updated: March 2021